Use of chymase inhibitors for the treatment of endometriosis, postoperative fibrosis, and diseases characterized by fibrosis

摘要

The present application relates to endometriosis, endometriosis-associated fibrosis, adenomyosis, and endometriosis, particularly for the treatment and / or prevention of diseases, especially the treatment and / or prevention of inflammatory and fibrotic diseases. It relates to the use of a Bicyclic-Substituted Uracil Derivative, alone or in combination with other active ingredients, for the treatment of pain associated with disorders and postoperative peritoneal fibrosis and adhesion formation.